USPTO Announces COVID-19 Prioritized Examination Pilot Program | Practical Law
The US Patent and Trademark Office (USPTO) is instituting a prioritized examination pilot program that does not require payment of certain prioritized examination fees, for certain COVID-19 related patent applications covering a product or process subject to US Food and Drug Administration (FDA) approval where the applicant is a small or micro entity.